Comments
Loading...
Molecular Partners Analyst Ratings and Price Targets | OTC:MLLCF | Benzinga
Molecular Partners Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Molecular Partners Corp from these most-recent analyst ratings.
Analyst Ratings for Molecular Partners
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Molecular Partners (MLLCF) stock?
There is no price target for Molecular Partners
What is the most recent analyst rating for Molecular Partners (MLLCF)?
There is no analyst for Molecular Partners
When was the last upgrade for Molecular Partners (MLLCF)?
There is no last upgrade for Molecular Partners
When was the last downgrade for Molecular Partners (MLLCF)?
There is no last downgrade for Molecular Partners.
When is the next analyst rating going to be posted or updated for Molecular Partners (MLLCF)?
There is no next analyst rating for Molecular Partners.
Is the Analyst Rating Molecular Partners (MLLCF) correct?
There is no next analyst rating for Molecular Partners.
Browse analyst ratings and price targets on all stocks.
